Loading...
XNAS
AQB
Market cap3mUSD
Jul 09, Last price  
0.92USD
1D
-2.59%
1Q
-1.97%
IPO
-99.83%
Name

AquaBounty Technologies Inc

Chart & Performance

D1W1MN
XNAS:AQB chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
16.35%
Rev. gr., 5y
96.45%
Revenues
0k
642,681281,07856,8690000000053,27884,518186,738127,6631,174,8323,136,954000
Net income
-18m
L-87.61%
-8,057,000-6,854,000-6,657,000-4,836,000-5,320,000-2,710,000-4,415,000-4,689,000-7,127,000-7,032,000-8,471,000-9,259,000-10,382,000-13,227,642-16,399,985-22,322,588-22,157,195-27,557,901-149,192,660-18,490,487
CFO
-8.74b
L+62,943.14%
000000-3,715,455-4,457,628-6,560,900-6,748,298-7,448,893-9,100,778-9,816,765-11,248,747-14,288,821-20,472,259-21,006,830-24,236,245-13,862,976-8,739,656,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
IPO date
Jan 09, 2017
Employees
100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT